Biomerica Dirección
Dirección controles de criterios 3/4
El CEO de Biomerica es Zack Irani , nombrado en Apr 1997, tiene una permanencia de 27.58 años. compensación anual total es $360.10K, compuesta por 41.7% salario y 58.3% primas, incluidas acciones y opciones de la empresa. posee directamente un 6.07% de las acciones de la empresa, por valor de $327.60K. La antigüedad media del equipo directivo y de la junta directiva es de 3.9 años y 7.5 años, respectivamente.
Información clave
Zack Irani
Chief Executive Officer (CEO)
US$360.1k
Compensación total
| Porcentaje del salario del CEO | 41.7% |
| Permanencia del CEO | 27.6yrs |
| Participación del CEO | 6.1% |
| Permanencia media de la dirección | 3.9yrs |
| Promedio de permanencia en la Junta Directiva | 7.5yrs |
Actualizaciones recientes de la dirección
Recent updates
Is Biomerica (NASDAQ:BMRA) In A Good Position To Deliver On Growth Plans?
Dec 20
Here's Why We're Watching Biomerica's (NASDAQ:BMRA) Cash Burn Situation
Aug 31We're Keeping An Eye On Biomerica's (NASDAQ:BMRA) Cash Burn Rate
Mar 04Amazon starts selling Biomerica's Aware Breast Self Exam device, EZ Detect test
Sep 29Biomerica: One To Watch Closely For The Future, But From The Sidelines For Now
Sep 09Biomerica reports FY results
Aug 29Biomerica stock jumps after Walmart to begin selling co's Aware Breast Self Exam device
Jul 14Most Shareholders Will Probably Find That The CEO Compensation For Biomerica, Inc. (NASDAQ:BMRA) Is Reasonable
Dec 03Biomerica (NASDAQ:BMRA) Is In A Good Position To Deliver On Growth Plans
Dec 02Is Biomerica Stock A Buy Or Sell After Q4 Earnings? Catalysts To Watch Into 2022
Sep 15Biomerica (BMRA) Investor Presentation - Slideshow
Jun 14Companies Like Biomerica (NASDAQ:BMRA) Are In A Position To Invest In Growth
Jun 13Biomerica, Inc.'s (NASDAQ:BMRA) Profit Outlook
Apr 04Should You Review Recent Insider Transactions At Biomerica, Inc. (NASDAQ:BMRA)?
Mar 08Companies Like Biomerica (NASDAQ:BMRA) Are In A Position To Invest In Growth
Feb 10The Biomerica (NASDAQ:BMRA) Share Price Has Soared 405%, Delighting Many Shareholders
Jan 15
Biomerica soars as its COVID-19 antigen test wins European nod
Jan 12When Will Biomerica, Inc. (NASDAQ:BMRA) Become Profitable?
Dec 20Biomerica clinical trial for IBS nears enrollment completion
Dec 09How Much Does Biomerica's (NASDAQ:BMRA) CEO Make?
Nov 23Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Aug 31 2024 | n/a | n/a | -US$6m |
| May 31 2024 | US$360k | US$150k | -US$6m |
| Feb 29 2024 | n/a | n/a | -US$6m |
| Nov 30 2023 | n/a | n/a | -US$6m |
| Aug 31 2023 | n/a | n/a | -US$6m |
| May 31 2023 | US$141k | US$141k | -US$7m |
| Feb 28 2023 | n/a | n/a | -US$7m |
| Nov 30 2022 | n/a | n/a | -US$6m |
| Aug 31 2022 | n/a | n/a | -US$5m |
| May 31 2022 | US$491k | US$135k | -US$5m |
| Feb 28 2022 | n/a | n/a | -US$4m |
| Nov 30 2021 | n/a | n/a | -US$7m |
| Aug 31 2021 | n/a | n/a | -US$7m |
| May 31 2021 | US$488k | US$137k | -US$7m |
| Feb 28 2021 | n/a | n/a | -US$6m |
| Nov 30 2020 | n/a | n/a | -US$5m |
| Aug 31 2020 | n/a | n/a | -US$4m |
| May 31 2020 | US$330k | US$137k | -US$2m |
| Feb 29 2020 | n/a | n/a | -US$3m |
| Nov 30 2019 | n/a | n/a | -US$2m |
| Aug 31 2019 | n/a | n/a | -US$2m |
| May 31 2019 | US$329k | US$137k | -US$2m |
| Feb 28 2019 | n/a | n/a | -US$2m |
| Nov 30 2018 | n/a | n/a | -US$2m |
| Aug 31 2018 | n/a | n/a | -US$2m |
| May 31 2018 | US$295k | US$137k | -US$1m |
Compensación vs. Mercado: La compensación total de Zack($USD360.10K) está por debajo de la media de empresas de tamaño similar en el mercado US ($USD647.72K).
Compensación vs. Ingresos: La compensación de Zack ha aumentado mientras la empresa no es rentable.
CEO
Zack Irani (58 yo)
27.6yrs
Permanencia
US$360,103
Compensación
Mr. Zackary S. Irani, also known as Zack, has been Chief Executive Officer of Biomerica Inc. since April 29, 1997 and is its Director and served as its President. He was Chairman of the Board at Biomerica...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO & Director | 27.6yrs | US$360.10k | 6.07% $ 327.6k | |
| Executive Vice-Chairman of the Board & Corporate Secretary | 25.1yrs | US$243.98k | 0.47% $ 25.1k | |
| Principal Accounting Officer & CFO | 1.7yrs | US$385.64k | 0% $ 0 | |
| Director of Manufacturing & Technical Operations | no data | sin datos | sin datos |
3.9yrs
Permanencia media
58yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de BMRA se considera experimentado (3.9 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO & Director | no data | US$360.10k | 6.07% $ 327.6k | |
| Executive Vice-Chairman of the Board & Corporate Secretary | 25.1yrs | US$243.98k | 0.47% $ 25.1k | |
| Chairman of Strategic Advisory Board | 8.3yrs | sin datos | sin datos | |
| Member of Strategic Advisory Board | 6.6yrs | sin datos | sin datos | |
| Member of the Scientific Advisory Board | no data | sin datos | sin datos | |
| Member of the Scientific Advisory Board | no data | sin datos | sin datos | |
| Independent Director | 17.6yrs | US$137.71k | 0.42% $ 22.8k | |
| Member of Scientific Advisory Board | 8.3yrs | sin datos | sin datos | |
| Independent Director | 1.9yrs | US$157.82k | 0% $ 0 | |
| Independent Director | 4.2yrs | US$145.21k | 0.26% $ 14.1k | |
| Chairman of Colorectal Screening Scientific Advisory Board | 3yrs | sin datos | sin datos | |
| Member of the Scientific Advisory Board | no data | sin datos | sin datos |
7.5yrs
Permanencia media
66yo
Promedio de edad
Junta con experiencia: La junta directiva de BMRA se considera experimentada (7.5 años de antigüedad promedio).